No Amendments Any Time Soon For EU Paediatric Regulation, Says Hotly Awaited Report
Executive Summary
The European Commission’s big report on the Paediatric Regulation which industry has been waiting for is finally out.
You may also be interested in...
EMA’s Pediatrics Group To Focus On ‘Stepwise’ PIPs & Using RWE In 2024
The European Medicines Agency has drawn up an action plan for its pediatrics committee that will see existing initiatives, such as the introduction of a ‘stepwise’ approach to pediatric investigation plans, further developed this year.
EU Evaluation Of Orphan & Pediatric Legislation Nears Completion
Spring 2020 should see the publication of a working document by the European Commission on how to improve the operation of the EU legislation on orphan and pediatric medicines. The commission has asked for more input from member state experts.
EU Launches Joint Assessment Of Pediatric & Orphan Drugs Legislation
A new European Commission consultation marks the launch of an evaluation exercise to assess the joint impact of the EU pediatric and orphan drugs legislation in supporting the development of pediatric medicines for rare diseases.